4:00 p.m. |
|
Other Tri-Institutional Events
Synthetic Biology for Synthetic Chemistry
Jay Keasling, Ph.D., professor, department of chemical and biomolecular engineering, professor, department of bioengineering, The Hubbard Howe Jr. Distinguished Professor of Biochemical Engineering, senior faculty scientist, Lawrence Berkeley National Laboratory, chief executive officer, Joint BioEnergy Institute (JBEI), University of California, Berkeley
|
9:00 a.m. |
|
Academic Symposia
JEM/JCB Cancer Symposium
Lewis Cantley, Ph.D., Meyer Director of the Sandra and Edward Meyer Cancer Center, professor of cancer biology in medicine, Weill Cornell Medicine and NewYork-Presbyterian Hospital, PI 3-Kinase and Cancer Metabolism Dafna Bar-Sagi, Ph.D., senior vice president and vice dean for science, chief scientific officer, professor, departments of biochemistry and molecular pharmacology, medicine, New York University School of Medicine, Oncogenic Ras-dependent Determinants of Tumor Fitness Golnaz Vahedi, Ph.D., M.Sc., assistant professor of genetics, University of Pennsylvania, Exploiting Chromatin Biology to Understand Gene Regulation in T Cells Ming Li, Ph.D., member, immunology program, Memorial Sloan Kettering Cancer Center, Immunity and Tolerance in Cancer Carol Prives, Ph.D., Da Costa Professor, department of cell and molecular biology, Columbia University, Travels with p53 and Mdm2—and Some Surprises along the Way Christopher Vakoc, M.D., Ph.D., principal investigator, associate professor, Cold Spring Harbor Laboratory, Lineage Reprogramming in Cancer Miriam Merad, M.D., Ph.D., professor of oncological science, medicine, and immunology, member, Immunology Institute and The Tisch Cancer Institute, Mount Sinai School of Medicine, Mapping Myeloid Cell Contribution to Cancer Lesions Jedd Wolchok, M.D., Ph.D., chief, melanoma and immunotherapeutics service, member and attending physician, Memorial Sloan Kettering Cancer Center, Immunologic Checkpoint Blockade: Dissecting Mechanisms and Next Steps
|